CA2699674C - 5-ht7 receptor antagonists - Google Patents

5-ht7 receptor antagonists Download PDF

Info

Publication number
CA2699674C
CA2699674C CA2699674A CA2699674A CA2699674C CA 2699674 C CA2699674 C CA 2699674C CA 2699674 A CA2699674 A CA 2699674A CA 2699674 A CA2699674 A CA 2699674A CA 2699674 C CA2699674 C CA 2699674C
Authority
CA
Canada
Prior art keywords
tetrahydro
pyrazol
methyl
ylmethyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2699674A
Other languages
English (en)
French (fr)
Other versions
CA2699674A1 (en
Inventor
Valentina O. Badescu
Sandra Ann Filla
Peter Thaddeus Gallagher
Maria Ann Whatton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CA2699674A1 publication Critical patent/CA2699674A1/en
Application granted granted Critical
Publication of CA2699674C publication Critical patent/CA2699674C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2699674A 2007-10-12 2008-09-30 5-ht7 receptor antagonists Expired - Fee Related CA2699674C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
US60/979,464 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (2)

Publication Number Publication Date
CA2699674A1 CA2699674A1 (en) 2009-04-16
CA2699674C true CA2699674C (en) 2013-07-16

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2699674A Expired - Fee Related CA2699674C (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Country Status (19)

Country Link
US (1) US7910588B2 (cg-RX-API-DMAC7.html)
EP (1) EP2201002B1 (cg-RX-API-DMAC7.html)
JP (1) JP5291716B2 (cg-RX-API-DMAC7.html)
KR (1) KR101161070B1 (cg-RX-API-DMAC7.html)
CN (1) CN101821257B (cg-RX-API-DMAC7.html)
AT (1) ATE548365T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008311154B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818450A2 (cg-RX-API-DMAC7.html)
CA (1) CA2699674C (cg-RX-API-DMAC7.html)
CY (1) CY1112709T1 (cg-RX-API-DMAC7.html)
DK (1) DK2201002T3 (cg-RX-API-DMAC7.html)
EA (1) EA016787B1 (cg-RX-API-DMAC7.html)
ES (1) ES2380756T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20120257T1 (cg-RX-API-DMAC7.html)
MX (1) MX2010003986A (cg-RX-API-DMAC7.html)
PL (1) PL2201002T3 (cg-RX-API-DMAC7.html)
PT (1) PT2201002E (cg-RX-API-DMAC7.html)
SI (1) SI2201002T1 (cg-RX-API-DMAC7.html)
WO (1) WO2009048765A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
MX2014004210A (es) 2011-10-11 2014-05-28 Ucb Pharma Sa Derivados de 2-oxo-piperidinilo.
ES2804545T3 (es) 2013-03-11 2021-02-08 Univ Temple Nuevos moduladores de la actividad del receptor de 5-hidroxitriptamina 7 y su método de uso
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 １－芳基－３－烷基吡唑殺蟲劑
EP3200589A4 (en) 2014-09-10 2018-07-25 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
KR102900157B1 (ko) 2016-11-15 2025-12-12 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 5-히드록시트립타민 수용체 7의 신규 조절제 및 이의 사용 방법
JP7365238B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション ５－ヒドロキシトリプタミン受容体７調節物質および治療剤としてのその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
WO2004067703A2 (en) * 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
JP2008501031A (ja) 2004-05-28 2008-01-17 バーテックス　ファーマシューティカルズ　インコーポレイテッド ムスカリン受容体のモジュレーター
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
KR20100054853A (ko) 2010-05-25
EA201070462A1 (ru) 2010-10-29
CN101821257A (zh) 2010-09-01
JP5291716B2 (ja) 2013-09-18
CA2699674A1 (en) 2009-04-16
AU2008311154B2 (en) 2013-09-26
EA016787B1 (ru) 2012-07-30
AU2008311154A1 (en) 2009-04-16
CN101821257B (zh) 2013-05-22
BRPI0818450A2 (pt) 2015-05-12
JP2011500575A (ja) 2011-01-06
SI2201002T1 (sl) 2012-04-30
US20100197700A1 (en) 2010-08-05
ATE548365T1 (de) 2012-03-15
DK2201002T3 (da) 2012-04-10
CY1112709T1 (el) 2016-02-10
EP2201002B1 (en) 2012-03-07
US7910588B2 (en) 2011-03-22
HRP20120257T1 (hr) 2012-04-30
EP2201002A1 (en) 2010-06-30
PT2201002E (pt) 2012-04-27
ES2380756T3 (es) 2012-05-18
WO2009048765A1 (en) 2009-04-16
KR101161070B1 (ko) 2012-07-13
PL2201002T3 (pl) 2012-07-31
MX2010003986A (es) 2010-04-27

Similar Documents

Publication Publication Date Title
CA2699674C (en) 5-ht7 receptor antagonists
CA2684563C (en) 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
US20070265258A1 (en) Quinazoline derivatives as phosphodiesterase 10 inhibitors
US20040224967A1 (en) Phenylaminopyrimidine derivatives and methods of use
KR20130028732A (ko) 4―아미노피리미딘 유도체 및 아데노신 ａ2ａ 수용체 안타고니스트로서의 이들의 용도
BRPI0616575A2 (pt) compostos e composições contendo diarilamina, seu uso como moduladores de receptores de c-kit bem como método para sua produção
AU2008293715B2 (en) Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists
US6281359B1 (en) Aminomethyl phenyl pyridine derivatives
WO2005063720A1 (ja) アミド誘導体及び医薬
RU2128176C1 (ru) Производные 2-аминопиразин-5-карбоксамида, способ их получения и содержащие их медицинский препарат и фармацевтическая композиция

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190930